Filing Flows

Filing Flows › Lexicon Pharmaceuticals (LXRX) › Who owns the stock

Who owns Lexicon Pharmaceuticals (LXRX) stock

146 funds reported Lexicon Pharmaceuticals (LXRX) shares in their latest 13F filings, worth $884M in all. The largest holder is Artal Group S.A. ($420M). Last quarter 75 funds added to their stakes and 66 cut them.

Largest holders of LXRX (13F)Largest holders of LXRX (13F)Artal Group S.A.$420MFMR LLC$124MSiren, L.L.C.$106MSessa Capital IM, L.P.$45.5MBlackRock$41.6MVanguard Capital Management LLC$23.8MPoint72 Asset Management, L.P.$19.8MGeode Capital Management, LLC$15.0MState Street$11.8MVanguard Group$11.0M

Largest holders (13F)

FundSharesValueChangeQuarter
Artal Group S.A.175,156,062$420Mincrease2026-06-30
FMR LLC51,782,045$124Mincrease2026-06-30
Siren, L.L.C.44,303,518$106Munchanged2026-06-30
Sessa Capital IM, L.P.18,960,836$45.5Mincrease2026-06-30
BlackRock17,348,741$41.6Mincrease2026-06-30
Vanguard Capital Management LLC9,901,208$23.8Mincrease2026-06-30
Point72 Asset Management, L.P.8,251,325$19.8Mincrease2026-06-30
Geode Capital Management, LLC6,244,372$15.0Mincrease2026-06-30
State Street4,917,769$11.8Mincrease2026-06-30
Vanguard Group9,606,549$11.0Mincrease2025-12-31
Vanguard Portfolio Management LLC2,357,749$5.7Mincrease2026-06-30
Northern Trust1,968,619$4.7Mincrease2026-06-30
Charles Schwab Investment Management1,956,775$4.7Mincrease2026-06-30
Vanguard Fiduciary Trust1,634,571$3.9Mincrease2026-06-30
Citadel Advisors LLC1,601,182$3.8Mincrease2026-06-30

Lexicon Pharmaceuticals' latest quarter

Lexicon Pharmaceuticals, Q3 2026: revenue $11.2M (-21% year over year), operating margin -128.8%, net loss $14.0M, operating cash flow −$8.1M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most LXRX stock?

By the latest 13F filings: Artal Group S.A. ($420M); FMR LLC ($124M); Siren, L.L.C. ($106M); Sessa Capital IM, L.P. ($45.5M); BlackRock ($41.6M).

What is the short interest in LXRX?

26,703,932 shares were sold short at the 2026-10-15 settlement, 3.39% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.